BOULDER, Colo.--(BUSINESS WIRE)--ArcherDX has expanded the application of its Anchored Multiplex PCR (AMP™) technology to include DNA variant detection with the VariantPlex™ Solid Tumor Panel. The ...
BOULDER, Colo.--(BUSINESS WIRE)--ArcherDX expands the application of its Anchored Multiplex PCR (AMP™) technology to include DNA variant detection with the Archer™ VariantPlex™ p53 Panel. The panel is ...
CORALVILLE, Iowa--(BUSINESS WIRE)-- Integrated DNA Technologies, a global leader in genomics solutions, proudly announces the expansion of its Archer™ next-generation sequencing (NGS) assay solutions ...
New drug AIMPILA targeted to AFP receptor: Oral anticancer therapy and biodistribution in vivo.
Hosted on MSN
IDT launches Archer VARIANTPlex lymphoma panel
Integrated DNA Technologies (IDT) has expanded its portfolio with the new Archer VARIANTPlex lymphoma panel, aimed at advancing blood cancer research. This tool is designed to detect genetic ...
ArcherDX and PierianDx announced a co-marketing and licensing agreements that will provide enhanced NGS testing capabilities to clinical labs. Under the terms of the agreement, PierianDx will ...
Archer CGP research assays now enable homologous recombination deficiency (HRD) assessment for identification of key biomarkers critical for cancer research CORALVILLE, Iowa--(BUSINESS WIRE)-- With a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results